Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Nutex Health (NUTX) Long-Term Debt Repayments (2018 - 2026)

Nutex Health (NUTX) has disclosed Long-Term Debt Repayments for 9 consecutive years, with $1.6 million as the latest value for Q1 2026.

  • For Q1 2026, Long-Term Debt Repayments fell 14.14% year-over-year to $1.6 million; the TTM value through Mar 2026 reached $11.1 million, up 50.53%, while the annual FY2025 figure was $11.4 million, 14.17% up from the prior year.
  • Long-Term Debt Repayments hit $1.6 million in Q1 2026 for Nutex Health, down from $3.1 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $8.7 million in Q3 2023 and bottomed at -$339008.0 in Q2 2023.
  • Average Long-Term Debt Repayments over 5 years is $2.7 million, with a median of $2.2 million recorded in 2024.
  • Year-over-year, Long-Term Debt Repayments surged 1685.12% in 2022 and then crashed 5886.11% in 2023.
  • Nutex Health's Long-Term Debt Repayments stood at $6.3 million in 2022, then fell by 6.22% to $5.9 million in 2023, then tumbled by 72.35% to $1.6 million in 2024, then soared by 87.11% to $3.1 million in 2025, then tumbled by 49.27% to $1.6 million in 2026.
  • According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at $1.6 million, $3.1 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.